Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07214467 · ClinicalTrials.gov registry record · NA

Individualized Adaptive Deep Brain Stimulation in Opioid Use Disorder

A NA study of Substance Use Disorder (SUD) and Opioid Use Disorder (OUD), sponsored by University of California, San Francisco.

Recruiting
Registry status
NA
Development phase
6
Enrollment target
1
Study location

NCT07214467 is a NA study of Substance Use Disorder (SUD) and Opioid Use Disorder (OUD) that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 6 participants, below the 249-participant average among 15 other Substance Use Disorder (SUD) trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07214467, a NA study of Substance Use Disorder (SUD) and Opioid Use Disorder (OUD), is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
NA
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if personalized (adaptive) Deep Brain Stimulation (DBS) based upon invasive brain mapping is safe and can lead to better outcomes like reductions in craving and opioid use.

Interventions

  • DEVICE Deep Brain Stimulation

Study Locations (1)

California

  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2025-10-24
Est. Completion 2031-11-22
Phase NA

What the Registry Record Tells You About NCT07214467

The ClinicalTrials.gov registry entry for NCT07214467 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 249-participant average among 15 other Substance Use Disorder (SUD) trials with a reported enrollment target (98% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Substance Use Disorder (SUD) appearing as the primary indexed condition, and to 1 intervention - of which Deep Brain Stimulation is the first listed.

NCT07214467 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT07214467 about?

NCT07214467 is a clinical study titled "Individualized Adaptive Deep Brain Stimulation in Opioid Use Disorder". The purpose of this study is to determine if personalized (adaptive) Deep Brain Stimulation (DBS) based upon invasive brain mapping is safe and can lead to better outcomes like reductions in craving and opioid use.

What is the current status of trial NCT07214467?

This trial is currently recruiting. It is a NA study. The enrollment target is 6 participants. The study started on 2025-10-24. Estimated completion is 2031-11-22.

What conditions does trial NCT07214467 study?

This clinical trial studies the following conditions: Substance Use Disorder (SUD), Opioid Use Disorder (OUD).

What interventions are being tested in trial NCT07214467?

The interventions under investigation include: Deep Brain Stimulation (DEVICE).

Who is sponsoring clinical trial NCT07214467?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07214467 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use Disorder (SUD)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.